206 related articles for article (PubMed ID: 4565264)
21. Effects of anabolic steroids in chronic renal failure. I. Short-term effects.
Sigler MH; Issekutz B
Arch Intern Med; 1967 Oct; 120(4):408-16. PubMed ID: 6058096
[No Abstract] [Full Text] [Related]
22. [Renal insufficiency in liver transplantation].
Rimola A
Nefrologia; 2002; 22 Suppl 5():69-71. PubMed ID: 12107922
[No Abstract] [Full Text] [Related]
23. [The hepatorenal syndrome in hepatic cirrhosis: risk factors and evolution].
Buligescu L; Costandache M; Moscaliu I; Copaci I
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(4):349-55. PubMed ID: 6131518
[No Abstract] [Full Text] [Related]
24. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].
Ackermann D
Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792
[TBL] [Abstract][Full Text] [Related]
25. Renal and intrarenal blood-flow in cirrhosis of the liver.
Kew MC; Brunt PW; Varma RR; Hourigan KJ; Williams HS; Sherlock S
Lancet; 1971 Sep; 2(7723):504-10. PubMed ID: 4105661
[No Abstract] [Full Text] [Related]
26. The 'hepatorenal' syndrome and refractory ascites. Successful therapy with the LeVeen-type peritoneal-venous shunt and valve.
Kinney MJ; Schneider A; Wapnick S; Grosberg S; LeVeen H
Nephron; 1979; 23(5):228-32. PubMed ID: 481657
[No Abstract] [Full Text] [Related]
27. Pharmacokinetics of furosemide in advanced renal failure.
Huang CM; Atkinson AJ; Levin M; Levin NW; Quintanilla A
Clin Pharmacol Ther; 1974 Oct; 16(4):659-66. PubMed ID: 4422027
[No Abstract] [Full Text] [Related]
28. Association between ratio of sodium to potassium in random urine samples and renal dysfunction and mortality in patients with decompensated cirrhosis.
Cholongitas E; Goulis J; Arsos G; Birtsou C; Nakouti T; Papadopoulou S; Chalevas P; Karakatsanis K; Akriviadis E
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):862-7. PubMed ID: 23403009
[TBL] [Abstract][Full Text] [Related]
29. Refractory ascites in cirrhosis.
Levinsky NG
Kidney Int; 1978 Jul; 14(1):93-102. PubMed ID: 682430
[No Abstract] [Full Text] [Related]
30. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
31. Reversible hyponatremia and azotemia in a patient with cirrhosis and ascites.
GALAMBOS JT; WILKINSON HA
Am J Dig Dis; 1962 Jul; 7():642-7. PubMed ID: 13896294
[No Abstract] [Full Text] [Related]
32. [The kidney in cirrhotics].
Jaillard J
Lille Med; 1969 Oct; 14(8):908-16. PubMed ID: 5402984
[No Abstract] [Full Text] [Related]
33. THE MACULA DENSA AND JUXTAGLOMERULAR BODY IN CIRRHOSIS.
REEVES G; LOWENSTEIN LM; PHIL D; SOMMERS SC
Arch Intern Med; 1963 Nov; 112():708-15. PubMed ID: 14058144
[No Abstract] [Full Text] [Related]
34. Ascites and oedema in liver disease.
Losowsky MS; Scott BB
Br Med J; 1973 Aug; 3(5875):336-8. PubMed ID: 4579401
[No Abstract] [Full Text] [Related]
35. Disorders of water and electrolyte metabolism in liver disease.
Summerskill WH; Barnardo DE; Baldus WP
Am J Clin Nutr; 1970 Apr; 23(4):499-507. PubMed ID: 4914609
[No Abstract] [Full Text] [Related]
36. [Acute renal failure in patients with liver cirrhosis--what to do? An update].
Gundling F; Gülberg V; Schepp W; Mann J
MMW Fortschr Med; 2008 Apr; 150 Suppl 1():22-6. PubMed ID: 18540328
[TBL] [Abstract][Full Text] [Related]
37. [Ascites and renal insufficiency in a 59-year-old male subjected to liver transplant for hepatocarcinoma on liver cirrhosis].
Terés J; Allende E
Med Clin (Barc); 1989 Apr; 92(14):547-55. PubMed ID: 2547122
[No Abstract] [Full Text] [Related]
38. The effects of decongestion operation on renal haemodynamics in patients with bilharzial hepatic fibrosis and ascites.
Badawi T; Abu-Zeina A; El-Sawy M; Abdel Fattah MM; Badawi H; Kilany MS; Hassab MA
J Trop Med Hyg; 1976 Sep; 79(9):201-4. PubMed ID: 1003591
[No Abstract] [Full Text] [Related]
39. Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients.
Salerno F; Borroni G; Lorenzano E; Solenghi D; Cazzaniga M; Bissoli F; Ceriani R; deFranchis R
Hepatology; 1996 May; 23(5):1135-40. PubMed ID: 8621145
[TBL] [Abstract][Full Text] [Related]
40. Management of chronic renal failure.
Moore J; Maher JF
Am Fam Physician; 1984 Aug; 30(2):204-13. PubMed ID: 6380252
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
